FlandersBio on Twitter

Follow us on Twitter

Archive for April 2011 - News

Archive for April 2011 - Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

ChondroCelect available and reimbursed in Belgium as of May 1, 2011

29.04.2011

Leuven (BELGIUM) – April 29, 2011 – TiGenix (NYSE EURONEXT: TIG) is pleased to announce that ChondroCelect® , its cell based medicinal product for cartilage repair in the knee, will be available and reimbursed for hospital use in Belgium with effect from May 1st2011. ChondroCelect is the first cell-based product that obtained acentralized European Marketing Authorization as an Advanced Therapy Medicinal Product (ATMP). Belgium is now the first country to provide national reimbursementfor an ATMP. read more

New sea vegetable: sea kale sprouts

29.04.2011

Bruyninckx ltd. and Intellicrops ltd announce the launch of a new sea vegetable: sea kale sprouts. Sea kale sprouts are the result of the forcing of sea kale roots. The fresh cream-coloured sprouts of 8 inch long are characterised by a soft kale taste that gives a special touch to fish or lamb plates. read more

Gimv, VIB and University of Antwerp invest EUR 2.0 million in molecular diagnostics startup Multiplicom

28.04.2011

​Gimv, Gimv managed Biotechfonds Vlaanderen, VIB and University of Antwerp (UA) together invest EUR 2.0 million in a Series-A funding round of Multiplicom, a Belgian startup focused on molecular diagnostics. Gimv and Gimv managed funds invest EUR 1.5 million. VIB and UA together invest the balance of EUR 0.5 million. read more

Kris Peeters opent grootste Europese regionale Life Sciences beurs in Gent op 5 mei

28.04.2011

De Vlaamse biotech kende de laatste jaren een belangrijke groei. Verschillende bedrijven brengen binnenkort voor het eerst producten op de markt. Andere bedrijven sloten cruciale samenwerkingsverbanden. Deze evoluties creëren een nieuwe betrokkenheid met patiënt en consument maar ook met financiële stakeholders. Knowledge for Growth 2011 focust op de impact van deze nieuwe ontwikkelingen en brengt dit jaar 1000 Life Sciences sprekers naar Gent. read more

QUINVITA and the Brazilian Bio-Jetfuel Platform sign a strategic alliance agreement on Jatropha curcas R&D

28.04.2011

The Brazilian Bio-Jetfuel Platform and the Industrial Crops Technology Company, QUINVITA announces today they entered into a strategic alliance on Research and Development of Jatropha production and processing. Under the signed agreement, QUINVITA joins the Brazilian Bio-Jetfuel Platform and will work with the partners of the Brazilian Bio-Jetfuel Platform on the deployment of its proprietary knowledge in Jatropha agronomy and processing. read more

Biocartis vestigt zich in Mechelen

28.04.2011

Met genoegen kan Biocartis mededelen dat zij gekozen heeft om haar productie eenheid en onderzoekscentrum naar Vlaanderen te brengen, meer bepaald in gebouwen van Intervest op de site van het Intercity Business Park te Mechelen. read more

ThromboGenics and BioInvent Have Dosed the First Patient in Phase IIb Trial of TB-402 (Anti-Factor VIII) for Venous Thromboembolism (VTE) Prophylaxis

27.04.2011

Leuven, Belgium and Lund, Sweden – 27 April 2011 – ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce today that the first patient has been dosed in a Phase IIb trial with their novel long-acting anticoagulant TB-402 (Anti-Factor VIII) for the prophylaxis of venous thromboembolism (VTE) after total hip surgery. read more

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top

Print